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Glomerular prostaglandins modulate vascular reactivity of the
downstream efferent arterioles
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Glomerular prostaglandins modulate vascular reactivity of the down-
stream efferent arterioles. The balance of vascular resistance in afferent
(Af—) and efferent arterioles (Ef.Arts) is a crucial factor that determines
glomerular hemodynamics. We have recently reported that when Ef-
Arts were perfused from the distal end of the Af-Art through the
glomerulus (orthograde perfusion; OP), both angiotensin II (Ang II) and
norepinephrine (NE) induced much weaker constriction than they did
when Ef-Arts were perfused from the distal end (retrograde perfusion;
RP). This difference was not affected by inhibiting synthesis of nitric
oxide. In the present study, we tested the hypothesis that glomerular
prostaglandins (PGs) may modulate vascular reactivity of the down-
stream Ef-Art. In addition, we examined the possible modulatory role
of PGs in the Af-Art responses to Ang II or NE. Both Ang II and NE
caused dose-dependent constriction of Ef-Arts with either OP or RP;
however, the constriction was stronger in RP. At l0 M, Ang II
decreased Ef-Art diameter by 35 3.5% in OP (N = 9)compared to 73
3.9% in RP (N = 5), while 106 M NE decreased the diameter by 25
3.6% in OP (N = 9) compared to 62 7.2% in RP (N = 5).
Pretreatment with 5 x l0 M indomethacin (Indo) did not alter basal
diameter with either method of perfusion. However, in OP it signifi-
cantly augmented the constriction induced by Ang II and NE; 108 M
Ang II and 106 M NE now decreased the diameter by 72 4.7% (N =
8; P < 0.01 vs. non-treated) and 48 3.3% (N = 7; P < 0.01),
respectively. In contrast, Indo had no effect on either Ang II- or
NE-induced constriction in Ef-Arts with RP. In vehicle-treated Af-Arts,
Ang II had no effect until the concentration reached l0 M, whereas it
began to cause significant constriction at concentrations as low as 10
M in Indo-treated Af-Arts. These results suggest that the resistance of
the Ef-Art may be regulated by PGs released by the upstream glomer-
ulus, while PGs synthesized within the Af-Art may modulate Ang II
action in the Af-Art.
Preglomerular afferent (Af—) and postglomerular efferent
arterioles (Ef-Arts) are crucial vascular segments to the control
of glomerular hemodynamics [1]. The balance of vascular tone
between Af- and Ef-Arts critically affects glomerular capillary
pressure (P0) and thereby the glomerular filtration rate (GFR)
as well as renal excretory function. Recent studies employing
isolated and nonperfused renal microvessels have shown that
sensitivity to angiotensin II (Ang II) is much higher or exclu-
sively present in the Ef-Art compared to the Af-Art [2—4]. Using
rabbit Al- and Ef-Arts microperfused in vitro (flow intact), we
have also shown higher Ang II sensitivity of the Ef-Art [5].
However, when Ef-Arts were perfused from the distal end of
the Af-Art through the glomerulus (orthograde perfusion; Fig.
lA, Ang. Il-induced constriction was much weaker than in
Ef.Arts perfused from the distal end (retrograde perfusion; Fig.
lB. Since the Ef-Art perfusate passes through the glomerulus
only in orthograde perfusion, these observations suggest that
vasoactive substances released by the glomerulus could modu-
late vascular responses in the downstream Ef-Art. In our
previous study, inhibiting synthesis of endothelium-derived
relaxing factor/nitric oxide (EDRF/NO) did not affect the dif-
ferences in Ef-Art reactivity observed with orthograde versus
retrograde perfusion, suggesting that other substances may be
involved.
One possible cause of such differences in Ef-Art reactivity
may be prostaglandin (PG), since the glomerulus is a major site
of its biosynthesis [6, 7]. It has been shown that inhibition of
cyclooxygenase augments the constrictor action of Ang II or
NE in both glomerular mesangial cells in culture and isolated
glomeruli [8, 9]. Micropuncture studies have shown that cy-
clooxygenase inhibitors augment Ang II action in both AT- and
Ef-Arts as well as the Ang Il-induced decrease in the glomerular
ultrafiltration coefficient [10]. Although these studies suggest
that the renal PG system plays an important role in the control
of glomerular hemodynamics, the mode of paracrine interac-
tions, such as the origin of the PGs involved and the mechanism
of action, is incompletely understood.
In the present study we tested the hypothesis that PGs
produced by the glomerulus modulate vascular reactivity in the
downstream Ef-Art. For this we perfused Ef-Arts in the ortho-
grade or retrograde direction at a controlled pressure compatible
with those seen under physiological conditions, and examined the
effect of the cyclooxygenase inhibitor on vasoconstriction induced
by Ang II or norepinephrine (NE). In addition, the paracnne role
of endogenous PGs and their interactions with EDRF/NO in the
Al-Arts were studied directly as well. We now present evidence
of a novel feedback mechanism in which the glomerulus con-
trols its own capillary pressure by releasing PGs and thereby
adjusting the resistance of the downstream Ef-Art.
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Isolation and microperfusion of the rabbit Af— and Ef-Art
We used methods similar to those described previously to
isolate and microperfuse Af— and Ef-Arts [5, 11, 12]. Briefly,
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Fig. 1. Efferent arteriole (El-Art) perfused in
an orthograde (A) and retrograde direction
(B). Abbreviations are: Perf-Pip, perfusion
pipette; Pre-Pip; pressure pipette; Af-Art,
afferent arteriole. Note that magnifications are
not the same.
young male New Zealand white rabbits (1.5 to 2.0 kg body wt),
fed standard rabbit chow (Ralston Purina, St. Louis, Missouri,
USA) and tap water ad libitum, were anesthetized with intra-
venous sodium pentobarbital (40 mg/kg) and given an intrave-
nous injection of heparin (500 U). The kidneys were removed
and sliced along the corticomedullary axis. Slices were placed
in ice-cold minimum essential medium (MEM: Gibco, Grand
Island, New York, USA) containing 5% BSA (Sigma Chemical,
St. Louis, Missouri, USA) and dissected under a stereomicro-
scope (SZH; Olympus, Tokyo, Japan) as described previously.
From each rabbit, a single superficial Af— and/or Ef-Art with its
glomerulus intact was microdissected. Using a micropipette,
the arteriole was transferred to a temperature-regulated cham-
ber mounted on an inverted microscope (IMT-2; Olympus) with
Hoffman modulation. The arteriole was cannulated with an
array of glass pipettes as described previously [11, 12] and
perfused with oxygenated medium 199 containing 5% BSA.
Intraluminal pressure was measured by Landis' technique,
using a fine pipette introduced into the arteriole through the
perfusion pipette, and was maintained at 60 mm Hg in the case
of Af-Arts.
We employed two approaches to study the response of
Ef-Arts, namely orthograde and retrograde perfusion [5]. For
orthograde perfusion, an Af-Art was microdissected together
with the glomerulus and attached Ef-Art (250 to 300 tm). The
Af-Art was cut short (—50 m) and cannulated as described
above, except that the perfusion pipette was advanced to the
end of the Af-Art (Fig. lA).The tip of the pressure pipette was
placed just beyond the distal end of the Af-Art, and intraluminal
pressure at this point was maintained at 50 mm Hg throughout
the experiment so as to eliminate the hemodynamic influences
of the Af-Art. In a previous study [5], we found that pressure in
the Ef-Art at a point 50 m distal to the glomerulus was
approximately 35 mm Hg under these experimental conditions.
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(1.) Effect of Ang II on Af- or Ef-Arts pretreated with either
indomethacin (Indo) or its vehicle. A stock solution of Indo
(Sigma), a cyclooxygenase inhibitor, was prepared in saline
containing 1.15 mg/mI sodium carbonate at a concentration of 5
x iO M. Indo or its vehicle was added to the bath and
arteriolar perfusate at a final concentration of S x i0 M from
the equilibration period to the end of the experiment. After the
30-minute equilibration period, increasing doses of Ang II
(10—" to 10—8 M; Sigma) were added to the bath. Luminal
diameter was measured immediately before adding Ang II and
observed for at least 3 minutes at each dose. We have previ-
ously shown that this dose of Indo blocks the effect of arachi-
donic acid (10—a M) on renin release in rabbit Af-Arts [13].
(2.) Effect of NE on Af- or Ef.Arts pretreated with either Indo
or its vehicle. The experimental design was identical to Protocol
1, except that NE (10—8 to 10_6 Sigma) was used instead of
Ang II.
(3.) Effect of nitro-L-arginine methyl ester (L-NAME) on Af-
or Ef-Arts pretreated with either Indo or its vehicle. We studied
the possibility of an interaction between PGs and EDRF/NO,
using L-NAME which inhibits EDRF/NO synthesis [14]. In this
protocol, Ef-Arts were only studied with orthograde perfusion,
because we found that L-NAME has no effect on Ef-Arts with
retrograde perfusion [5]. After the equilibration period (with
either Indo or vehicle), increasing doses of L-NAME (10—v to
i0" Sigma) were added to the lumen. Luminal diameter was
I I
measured immediately before adding L-NAME and observed
for at least 15 minutes at each dose.0 —11 —10 —9 —8 (4.) Effect of Ang II on Af- or Ef-Arts pretreated with both
Indo and L-NAME. We found no effect of Indo on L-NAME-
induced constriction in either Af- or Ef-Arts (Results), suggest-
ing that there is no interaction between PGs and EDRF/NO
under basal conditions. In this protocol, we examined their
possible interactions in modulating Ang II action. As in proto-
col 3, Ef-Arts were studied with orthograde perfusion alone.
After the equilibration period in the presence of Indo, i0 M
L-NAME was added to the arteriolar perfusate. Fifteen minutes
later, the effect of Ang II was examined as in protocol 1 and the
results compared with those obtained in protocol 1. We have
previously shown that at this concentration L-NAME blocks
acetyicholine-induced vasodilation in Af- and Ef-Arts precon-
stricted with NE [5, 12].
Art.
The bath was identical to the arteriolar perfusate except that
it contained 0.1% BSA, and was exchanged continuously.
Microdissection and cannulation of the arteriole were com-
pleted within 90 minutes at 8°C, after which the bath was
gradually warmed to 37°C for the rest of the experiment. Once
the temperature was stable, a 30-minute equilibration period
was allowed before taking any measurements. Images of the
arteriole were displayed at magnifications up to l,980x and
recorded with a video system consisting of a camera (DXC-755;
Sony, Tokyo, Japan), monitor (PVM1942Q; Sony) and video
recorder (EDV-9500; Sony). The diameter at the most con-
stricted point (which was located at a segment within 50 m of
the glomerulus) was measured with an image-analysis system
(Fryer, Carpentersville, Illinois, USA).
Experimental protocols
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Fig. 2. Effects of indomethacin on angiotensin Il-induced vasocon-
striction in afferent arterioles. , ** P < 0.05 and 0.01, respectively,
compared with vehicle-treated arterioles. Note that indomethacin pre-
treatment significantly augmented angiotensin Il-induced vasoconstric-
tion,
For retrograde perfusion, most of the Af-Art was removed and
the Ef-Art (100 to 150 m) perfused from its distal end (Fig. 1B)
at 35 mm Hg. In this preparation, there was no influence by
vasoactive substances produced by the glomerulus and/or Af-
Data analysis
Values were expressed as mean SEM, and all statistical
analyses were done using per cent change from control values.
Paired t-tests were used to examine whether the diameter at a
given concentration differed from the control value within each
group. When more than one comparison was made, Bonferro-
ni's multiple comparison adjustment was used to reduce the
significance level of each paired t-test from 0.05 to 0.0125
(0.05/4; Bonferroni's adjustment for four dose levels). A two-
sided Student's t-test (or Welch's test if variances were un-
equal) was used to examine whether the change in diameter at
a given concentration differed between two groups. For this
analysis, P < 0.05 was considered significant.
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Results
Effect of Ang II on Af- or Ef-Arts pretreated with either Indo
or its vehicle.
Basal luminal diameter of vehicle- or Indo-treated Af-Arts
was not different from each other, with a mean value of 16.1
0.9 sm (N = 11) and 17.7 0.6 tm (N = 9), respectively. As
shown in Figure 2, Ang II had no effect on the vehicle-treated
Af-Arts until the concentration reached iO M, which de-
creased luminal diameter by 2.0 0.5 j.m or 12 2.5% (P <
0.001); at 10—8 M, the diameter decreased by 6.8 1.1 m or 40
5.3% (P < 0.0002). On the other hand, in Indo-treated
Af-Arts, Ang II at concentrations as low as 10_It M induced a
slight but significant constriction (1.3 0.3 m or 6.9 1.5%;
P < 0.002). Compared to vehicle-treated Af-Arts, Ang II-
induced vasoconstriction was stronger in Indo-pretreated Af-
Arts at doses of 10— 10'° and iO but not 10—8 M.
Basal luminal diameter of vehicle- or Indo-treated Ef-Arts
perfused in an orthograde direction was 15.7 0.6 m (N = 9)
and 14.3 0.5 pm (N = 8), respectively, while corresponding
values for retrograde perfusion were 16.3 1.3 pm (N 5) and
15.4 0.4 jsm (N = 5); these values were not statistically
different. As shown in Figure 3, in vehicle-treated Ef-Arts, Ang
Il-induced vasoconstriction was much stronger in retrograde
than in orthograde perfusion. Thus the decrease in diameter at
10_8 M was only 5.3 0.6 m or 35 3.5% in orthograde
perfusion compared to 12.0 0.8 pm or 73 3.9% in
retrograde perfusion. With orthograde perfusion, Indo pretreat-
ment significantly augmented Ang Il-induced constriction, with
the decrease in diameter at 108 M becoming 10.3 0.8 pm or
72 4.7% (P < 0.001 vs. vehicle). Compared to vehicle-treated
Ef-Arts, Ang Il-induced constriction was significantly stronger
in Indo-treated Ef-Arts at doses of iO and 108 M. In marked
contrast, Indo pretreatment had no effect in Ef-Arts with
retrograde perfusion, thereby markedly diminishing the differ-
ences in Ang II action between orthograde and retrograde
perfusion.
Effect of NE on Af- or Ef-Arts pretreated with either Indo or
its vehicle
Basal luminal diameter of vehicle- or Indo-treated Af-Arts
was not different from each other, with a mean value of 16.2
0.9 m (N = 7) and 17.8 0.7 m (N = 7), respectively. As
shown in Figure 4, NE had no effect on vehicle-treated Af-Arts
until the concentration reached l0 M, which decreased lumi-
nal diameter by 1.9 0.3 m or 12 1.8% (P < 0.001); at 5 x
l0— and 10—6 M, the decrease was 7.3 0.5 m (45 3.3%)
and 12.2 1.1 m (76 6.1%), respectively. Indo pretreatment
had only a minor effect on NE-induced constriction in Af-Arts.
Thus, NE-induced constriction was stronger in Indo-treated
than vehicle-treated Af-Arts, but only at 108 M (1.3 0.2 m
or 7.3 1.0% vs. 0.4 0.2 m or 1.9 1.5%; P < 0.02).
Basal luminal diameter of vehicle- or Indo-treated Ef-Arts
perfused in an orthograde direction was 14.8 0.5 pin (N = 9)
and 14.3 0.4 m (N = 7), respectively, while corresponding
values for retrograde perfusion were 14.6 1.4 m (N 5) and
14.7 0.1 jsm (N = 5); these values were not statistically
different. As shown in Figure 5, in vehicle-treated Ef-Arts
NE-induced vasoconstriction was much stronger in retrograde
than in orthograde perfusion. Thus the decrease in diameter at
106 M was only 3.8 0.6 m (25 3.6%) in orthograde
perfusion compared to 8.8 1.2 m (62 7.2%) in retrograde
perfusion. In orthograde perfusion, Indo pretreatment signifi-
cantly augmented NE-induced constriction, with the decrease
in diameter at 10_6 M becoming 6.9 0.5 m or 48 3.3% (P
< 0.001 vs. vehicle). Compared to vehicle-treated Ef-Arts,
A Orthograde perfusion B Retrograde perfusion
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Fig. 3. Effects of indomethacin on
angiotensin 11-induced vasoconstriction in
efferent arterioles with orthograde (A) and
retrograde perfusion (B). **D < 0.01
___________________________
compared with vehicle-treated arterioles. Note
0 —11 —10 —9 —8 that indomethacin pretreatment significantly
augmented angiotensin IL-induced
vasoconstriction in efferent arterioles with
Angiotensin H, log M orthograde but not retrograde perfusion.
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NE-induced constriction was significantly stronger in Indo-
treated Ef-Arts at doses of l0—, S x l0— and 10_6 M. In
marked contrast, Indo pretreatment had no effect in Ef-Arts
with retrograde perfusion, thereby abolishing the differences in
NE action between orthograde and retrograde perfusion.
Effect of L-NAME on Af- or Ef-Arts pretreated with either
Indo or its vehicle
Basal luminal diameter of vehicle- or Indo-treated Af-Arts
were not different from each other, with a mean value of 17.4
0.8 pm (N = 11) and 17.3 0.5 m (N = 6), respectively.
Corresponding values for Ef-Arts were 14.7 0.7 pm (N = 8)
and 13.7 0.8 p.m (N = 7), which were not statistically
different. Indo pretreatment had no effect on L-NAME-induced
vasoconstriction in either Af- or Ef-Arts, whether compared
using percent change (Fig. 6) or absolute change. The absolute
decrease in diameter induced by L-NAME at l0—, 106, l0—
and l0— M was 0.5 0.2, 1.0 0.1,2.6 0.2 and 3.9 0.3 p.m
in vehicle-treated Af-Arts, and 0.2 0.1, 0.6 0.4, 1.5 0.6
and 4.0 0.5 p.m in Indo-treated M-Arts. The corresponding
values for vehicle-treated Ef-Arts were 0.5 0.2, 0.7 0.2, 1.0
0.3 and 1.4 0.3 p.m, while those for Indo-treated Ef-Art
were 0.1 0.2, 0.5 0.2, 1.2 0.1 and 1.9 0.4 p.m.
Effect of Ang II on Af- or Ef-Arts pretreated with both Indo
and L-NAME
L-NAME at l0— M decreased luminal diameter from 18.2
0.8 to 14.5 1.0 p.m in Indo-treated Af-Arts (N = 6) and from
15.1 0.8 to 13.3 0.8 p.m in Indo-treated Ef-Arts (N = 7).
When arterioles were already treated with Indo, L-NAME had
no effect on Ang II action in either Af- or Ef-Arts, whether
compared using percent change (Fig. 7) or absolute change. The
absolute decrease in diameter induced by Ang H at l0 ",
10b0, 1O and 108 M, was 1.3 0.3, 2.2 0.5, 4.2 0.8 and
7.3 0.7 p.m in Af-Arts pretreated with Indo alone, and 1.4
0.3, 2.3 0.7, 4.5 0.8 and 7.8 1.5 p.m in M-Arts pretreated
with both Indo and L-NAME. The corresponding values for
Ef-Arts pretreated with Indo alone was 1.6 0.3, 3.5 0.5, 5.3
0.4 and 6.9 0.5 pm, while those for Ef-Arts pretreated with
both Indo and L-NAME were 2.0 0.3, 2.7 0.4, 4.4 0.5
and 8.6 0.8 p.m.
Discussion
The relative sensitivity of the glomerular Af- versus Ef-Art to
Ang II or NE remains controversial. In isolated and nonper-
fused Af- and Ef-Arts, sensitivity to Ang II has been reported to
• be much higher or exclusively present in the Ef-Art, while NE
has been shown to cause similar effects in both arterioles [2, 31.j On the other hand, injuxtamedullary nephrons perfused in vitroor hydronephrotic kidneys, Ang II produces a similar effect in
both Af- and Ef-Arts, while constriction induced by NE or renal
________
nerve stimulation is much weaker in Ef-Arts [4, 15, 161. Of
—6 particular note is the fact that the response of Ef-Arts to Ang II
or NE is much weaker in both juxtamedullary nephrons and
hydronephrotic kidneys [4, 15, 16] than in isolated vessels [2,
3]. This difference may be related to the fact that the Ef-Art is
perfused through the glomerulus in the former but not the latter
preparations. Consistent with this hypothesis, our present as
well as previous studies [5] demonstrate that both Ang II- and
NE-induced constriction of Ef-Arts are much weaker in ortho-
grade perfusion (through the glomerulus) than in retrograde
perfusion. The difference in Ef-Art reactivity was not affected
by pretreatment with L-NAME [5] but was markedly dimin-
ished or abolished by Indo. This suggests that PGs (rather than
EDRF/NO) released by the glomerulus can reach the down-
stream Ef-Art at high enough concentrations to attenuate Ang
II- or NE-induced constriction. This may be a novel feedback
mechanism whereby the glomerulus controls its own capillary
pressure and thus the rate of ultrafiltration.
We found that in Af-Arts Indo augmented the vasoconstrictor
action of Ang II significantly, but had little effect on NE action.
On the other hand, several in vivo studies have shown that
cyclooxygenase inhibitors augment the renal action of both Ang
II and NE [17—19]. However, since NE action may have been
partially mediated by increased Ang II levels as a result of
NE-stimulated renin release, it may be that the apparent effect
of cyclooxygenase inhibition on NE-induced constriction was
due to augmentation of Ang II rather than NE action. Indeed,
Pelayo [20] reported that the increase in Af-Art resistance
induced by renal nerve stimulation was augmented by Indo, but
this effect was abolished by blocking Ang II with either con-
verting-enzyme inhibitors or Ang II receptor antagonists. This
may be consistent with our finding that Indo had a minimal
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Fig. 4. Effects of indomethacin on norepinephrine-induced vasocon-
striction in afferent arterioles. < 0.05. Note that indomethacin
pretreatment had only a minor effect on NE-induced vasoconstriction.
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Fig. 5. Effects of indomethacin on
norepinephrine-induced vasoconstriction in
efferent arterioles with orthograde (left) and
retrograde perfusion (right). **D < 0.01
I compared with vehicle-treated arterioles. Note
0 7 that indomethacin pretreatment significantly
—o —,
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vasoconstriction in efferent arterioles with
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Fig. 6. Effects of indomethacin on L-NAME-
induced vasoconstriction in afferent (A) and
I I I efferent arterioles with orthograde perfusion
.7 (B). Note that indomethacin pretreatment had
— ' ' no effect on L-NAME-induced
vasoconstriction in either afferent or efferent
L-NAME, log M arterioles with orthograde perfusion.
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effect on NE action in the Af-Art. (Since the Af-Art perfusate
contained no angiotensinogen, the Ang II level would likely
remain low even during exposure to NE in our preparation.)
However, the reason why Indo augmented Ang II much more
than NE action is not clear, though it is possible that Ang II
stimulated PG synthesis more than NE did [211.
In contrast to our findings, Yuan, Robinette and Conger [31
reported that Indo had no effect on the vasoconstnctor action of
Ang II in isolated nonperfused rat Af-Arts. The reason for this
discrepancy may be related to differences in species studied
and/or the presence or absence of luminal flow. It is conceivable
that flow and Ang II acted synergistically to stimulate PG
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synthesis, resulting in greater modulation of Ang II action in our
preparation (flow present) than in Yuan's (no flow). Indeed, we
have recently observed that Indo augmented Ang II action more
in free-flow than in non-flow rabbit Af-Arts (unpublished data).
Although our results strongly support endogenous PGs as an
important modulator of Af- and Ef-Art reactivity, the specific
PG involved is unclear. It has been reported that the predomi-
nant PG synthesized in isolated rabbit Af-Arts is PG!2 [22],
whereas PGE2 accounts for the largest portion (60%) of total
prostanoids produced by the glomerulus [6, 23]. However, the
glomerulus also produces PGI2 (20% of total PGs [6]), and its
concentration in the Ef-Art could reach substantial levels
because of the huge number of endothelial and mesangial cells
in the glomerulus. When administered exogenously, PGI2 and
PGE2 caused vasodilation in isolated rabbit Af-Arts, whereas in
Ef-Arts PGI2 counteracted Ang H- or NE-induced vasocon-
striction while PGE2 did not [24]. Thus it may be speculated
that PG!2 synthesized in the Af-Art modulates its response to
Ang II, whereas PGI2 released from the glomerulus modulates
the vascular response to both Ang II and NE in the downstream
Ef-Art.
In normal animals, intrarenal infusion of arachidonic acid has
been shown to increase renal blood flow (RBF) without altering
the GFR [25—271. These effects were blocked by cyclooxygen-
ase inhibitors, suggesting that enhancing endogenous PG syn-
thesis causes the Ef-Art (and possibly the Al-Art) to dilate.
When administered to normal conscious animals, cyclooxygen-
ase inhibitors generally have no significant effect on renal
function [28]. On the other hand, under conditions where the
Ang II level is increased, such as sodium depletion [29],
laparotomy [30], anesthesia [30] and congestive heart failure
[31, 32], inhibition of PG synthesis causes a profound decrease
in both the GFR and RBF as the result of increased Af- and
Ef-Art resistance as well as a decrease in the glomerular
ultrafiltration coefficient. Consistent with in vivo studies, Indo
was found to augment the vasoconstriction induced by Ang II at
low (10— and l0'° M) to modestly high concentrations (l0
M) only in the Al-Art, or in both Af- and Ef-Arts. On the other
hand, when the Ang II concentration reached 10—8 M, Indo was
found to augment Ef-Art but not Af-Art constriction. Thus,
under certain conditions in which Ang II concentration is
extremely high, PG inhibition may cause more pronounced
constriction in the Ef- than in the Al-Art. This would increase
POC and act to minimize the decrease in single nephron GFR.
However, a massive constriction of Ef-Arts (as much as 72% in
the present study) together with substantial Af-Art constriction
(4 1%) would cause profound diminution of glomerular plasma
flow (QA). Such a decrease in QA would override the effect of
increased GC, and thus the net result would be marked
reduction of both GFR and RBF. Furthermore, since glomeru-
lar hypertension may cause structural damages, an increased
P0 may contribute to the rapidly progressive renal failure seen
in malignanthypertension, which canbe inducedbycyclooxygen-
ase inhibitors in renin-dependent hypertension [33].
In the present study, Indo had no effect on the L-NAME-
induced decrease in basal diameter of Af-Arts, indicating that
PGs do not modify L-NAME's effect in our preparation. When
given separately, both Indo and L-NAME [5] significantly
augmented Ang II action in Al-Arts. However, further augmen-
tation was not observed when both L-NAME and Indo were
given simultaneously, suggesting that their effects were not
additive. These results may indicate that although there is little
interaction between EDRF/NO and PGs under basal condi-
tions, interaction may become apparent when PG synthesis is
stimulated by exposure to Ang II, for example. Shimokawa et al
[34] reported that exogenous PGI2 relaxed porcine coronary
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Fig. 7. Effects of L-NAME on angiotensin
If-induced vasoconstriction in indomethacin-
pretreated afferent (A) and efferent arterioles
with orthograde perfusion (B). Note that L-
NAME had no effect on angiotensin II-0 11 —10 9 induced vasoconstriction in either
indomethacin-pretreated afferent or efferent
Angiotensin II, log M arterioles with orthograde perfusion.
Arima et a!: PGs in afferent and efferent arterioles 657
artery strips more in the presence of intact endothelium than in
its absence, and that oxyhemoglobin abolished this difference.
They have further shown that forskolin, which directly stimu-
lates cAMP production [35, 361, had the same effects as PGI2.
They speculated that PGI2 (via cAMP) may stimulate
EDRF/NO release and/or act in a synergistic manner with
EDRF/NO. In addition, Salvemini et a! [37] recently reported
that NO directly activates cyclooxygenase enzymes, while
Graier et a! [381 have shown that increased endothelial cAMP
amplifies agonist-induced synthesis of EDRF/NO. Since Ang II
stimulates synthesis of PGI2, which in turn increases intracel-
lular cAMP [391, it may be that interaction between PGs and
EDRFINO became apparent only in the presence of Ang II
under our experimental conditions.
In summary, we provide evidence that PGs released by the
glomerulus reach the downstream Ef-Art and control its vascu-
lar reactivity. We have shown that both Ang II and NE cause
much weaker constriction of the Ef-Art in orthograde perfusion
through the glomerulus than in retrograde perfusion, and that
these differences are markedly diminished or abolished by the
cyclooxygenase inhibitor Indo. Thus the glomerulus may con-
trol its own capillary pressure and hence the rate of ultrafiltra-
tion by releasing PGs and thereby adjusting the resistance of the
downstream Ef-Art.
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